We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
How investigators and sponsors should manage clinical trials during COVID-19
Find out who can get a free rapid lateral flow test, how to use the test and what your test result means.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Information on COVID-19, including guidance on the assessment and management of suspected UK cases.
Information on the reporting, investigation and management of acute flaccid paralysis (AFP) and acute flaccid myelitis (AFM).
Advice and guidance on the health needs of migrant patients from El Salvador for healthcare practitioners.
This document explains: how patients are tested and treated, and steps in place to prevent its spread.
If you’re travelling abroad, it's important to take out appropriate travel insurance before you go.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Advice and guidance on the health needs of migrant patients from Argentina for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Colombia for healthcare practitioners.
Information about the EU Regulations and their implementation in Northern Ireland
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Actions that trial sponsors should consider to build resilience into clinical trial design
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. NICE is an executive non-departmental public body, sponsored by the Department of Health and Social Care .
Advice and guidance on the health needs of migrant patients from Paraguay for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Uruguay for healthcare practitioners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.